...
首页> 外文期刊>Journal of gastroenterology >Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCT
【24h】

Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCT

机译:肝癌和增生性结节的Gd-EOB-DTPA增强MRI评估以及检测灵敏度与MDCT的比较

获取原文
获取原文并翻译 | 示例
           

摘要

Background We aimed to evaluate gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA)- enhanced magnetic resonance imaging (MRI) for the detection of hepatocellular carcinomas (HCCs) and dysplastic nodules (DNs) compared with dynamic multi-detector row computed tomography (MDCT), and to discriminate between HCCs and DNs. Methods Eighty-six nodules diagnosed as HCC or DNs were retrospectively investigated. Gd-EOB-DTPA-enhanced MRI and dynamic MDCT were compared with respect to their diagnostic ability for hypervascular HCCs and detection sensitivity for hypovascular tumors. The ability of hepatobiliary images of Gd-EOB-DTPA-enhanced MRI to discriminate between these noduleswas assessed.Wealso calculated the EOB enhancement ratio of the tumors. Results For hypervascular HCCs, the diagnostic ability of Gd-EOB-DTPA-enhanced MRI was significantly higher than that of MDCT for tumors less than 2 cm (p = 0.048). There was no difference in the detection of hypervascular HCCs between hepatobiliary phase images of Gd-EOBDTPA- enhanced MRI (43/45: 96%) and dynamic MDCT (40/45: 89%), whereas the detection sensitivity of hypovascular tumors by Gd-EOB-DTPA-enhanced MRI was significantly higher than that by dynamic MDCT (39/41: 95% vs. 25/41: 61%, p = 0.001). EOB enhancement ratios were decreased in parallel with the degree of differentiation in DNs and HCCs, although there was no difference between DNs and hypovascular well-differentiated HCCs. Conclusion The diagnostic ability of Gd-EOB-DTPAenhanced MRI for hypervascular HCCs less than 2 cm was significantly higher than that of MDCT. For hypovascular tumors, the detection sensitivity of hepatobiliary phase images of Gd-EOB-DTPA-enhanced MRI was significantly higher than that of dynamic Gd-EOB-DTPA-enhanced MRI and dynamic MDCT. It was difficult to distinguish between DNs and hypovascular well-differentiated HCCs based on the EOB enhancement ratio.
机译:背景我们旨在评估aimed乙氧基苄基二亚乙基三胺五乙酸(Gd-EOB-DTPA)增强的磁共振成像(MRI)与动态多排行计算机断层扫描技术相比的检测,以检测肝细胞癌(HCC)和增生性结节(DN)。 MDCT),并区分HCC和DN。方法回顾性分析86例诊断为HCC或DN的结节。比较了Gd-EOB-DTPA增强的MRI和动态MDCT在高血管HCC的诊断能力和对血管不足肿瘤的检测灵敏度方面的优势。评估了Gd-EOB-DTPA增强MRI的肝胆图像区分这些结节的能力。我们还计算了肿瘤的EOB增强率。结果对于高血管肝癌,对于小于2 cm的肿瘤,Gd-EOB-DTPA增强的MRI的诊断能力显着高于MDCT(p = 0.048)。 Gd-EOBDTPA增强的MRI(43/45:96%)和动态MDCT(40/45:89%)的肝胆期图像对高血管HCC的检测没有差异,而Gd对血管下肿瘤的检测敏感性-EOB-DTPA增强的MRI显着高于动态MDCT(39/41:95%,25/41:61%,p = 0.001)。 DNs和HCC的分化程度并行地降低了EOB增强率,尽管DNs和低分化的HCCs之间没有差异。结论Gd-EOB-DTPA增强MRI对2 cm以下的高血管肝癌的诊断能力明显高于MDCT。对于血管下肿瘤,Gd-EOB-DTPA增强的MRI对肝胆期图像的检测灵敏度显着高于动态Gd-EOB-DTPA增强的MRI和动态MDCT。基于EOB增强率,很难区分DN和血管低分化的HCC。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号